Prolactinoma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Bot: Removing from Primary care) |
||
| (7 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Prolactinoma}} | {{Prolactinoma}} | ||
{{CMG}} {{AE}} | {{CMG}};{{AE}} {{Anmol}}, {{Faizan}} | ||
==Overview== | ==Overview== | ||
45% of [[pituitary adenoma|pituitary adenomas]] are [[prolactinomas]], making it the most common type of all [[pituitary adenoma|pituitary adenomas]]. | About 45% of [[pituitary adenoma|pituitary adenomas]] are [[prolactinomas]], making it the most common type of all [[pituitary adenoma|pituitary adenomas]]. Worldwide, the [[prevalence]] of sporadic [[prolactinoma]] is 6 to 10 per 100,000 persons. The [[prevalence]] of [[prolactinoma]] in people less than 20 years old is 10 per 100,000 individuals worldwide. [[Prolactinoma]] most commonly affects women in reproductive age group (20 to 50 years). [[Prolactinoma]] is more common in females than males in people between 20 and 50 years old. Distribution among males and females becomes similar after age 50. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Prevalence=== | ===Prevalence=== | ||
* | *45% of [[pituitary adenoma|pituitary adenomas]] are [[prolactinomas]], making it the most common type of all [[pituitary adenoma|pituitary adenomas]].<ref name="pmid16411062">{{cite journal| author=Ciccarelli A, Daly AF, Beckers A| title=The epidemiology of prolactinomas. | journal=Pituitary | year= 2005 | volume= 8 | issue= 1 | pages= 3-6 | pmid=16411062 | doi=10.1007/s11102-005-5079-0 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16411062 }} </ref> | ||
* | *Worldwide, the [[prevalence]] of sporadic [[prolactinoma]] ranges from a low of 6 persons per 100,000 persons to a high of 10 persons per 100,000 persons. | ||
*Clinically significant [[pituitary tumors]] affect the health of approximately 14 | *Worldwide, the [[prevalence]] of [[prolactinoma]] in people less than 20 years old is 10 individuals per 100,000 individuals. | ||
*Clinically significant [[pituitary tumors]] affect the health of approximately 14 people per 100,000 people in United States. | |||
*Some [[growth hormone]]-producing tumors also co-secrete [[prolactin]]. | *Some [[growth hormone]]-producing tumors also co-secrete [[prolactin]]. | ||
*Microprolactinoma are much more common than macroprolactinoma. | *Microprolactinoma are much more common than macroprolactinoma. | ||
===Incidence=== | ===Incidence=== | ||
*Worldwide, the incidence of sporadic [[prolactinoma]] is | *Worldwide, the [[incidence]] of sporadic [[prolactinoma]] is 1 person per 100,000 persons per year.<ref name="pmid16411062">{{cite journal| author=Ciccarelli A, Daly AF, Beckers A| title=The epidemiology of prolactinomas. | journal=Pituitary | year= 2005 | volume= 8 | issue= 1 | pages= 3-6 | pmid=16411062 | doi=10.1007/s11102-005-5079-0 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16411062 }} </ref> | ||
===Age=== | ===Age=== | ||
* Age specific distribution of [[prolactinoma]] is as follows:<ref name="pmid16411062">{{cite journal| author=Ciccarelli A, Daly AF, Beckers A| title=The epidemiology of prolactinomas. | journal=Pituitary | year= 2005 | volume= 8 | issue= 1 | pages= 3-6 | pmid=16411062 | doi=10.1007/s11102-005-5079-0 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16411062 }} </ref><ref name="pmid7893282">{{cite journal| author=Mindermann T, Wilson CB| title=Age-related and gender-related occurrence of pituitary adenomas. | journal=Clin Endocrinol (Oxf) | year= 1994 | volume= 41 | issue= 3 | pages= 359-64 | pmid=7893282 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7893282 }} </ref> | * Age specific distribution of [[prolactinoma]] is as follows:<ref name="pmid16411062">{{cite journal| author=Ciccarelli A, Daly AF, Beckers A| title=The epidemiology of prolactinomas. | journal=Pituitary | year= 2005 | volume= 8 | issue= 1 | pages= 3-6 | pmid=16411062 | doi=10.1007/s11102-005-5079-0 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16411062 }} </ref><ref name="pmid7893282">{{cite journal| author=Mindermann T, Wilson CB| title=Age-related and gender-related occurrence of pituitary adenomas. | journal=Clin Endocrinol (Oxf) | year= 1994 | volume= 41 | issue= 3 | pages= 359-64 | pmid=7893282 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7893282 }} </ref> | ||
**[[Prolactinoma]] commonly affects individuals between 20 and 50 years old. | **[[Prolactinoma]] commonly affects individuals between 20 and 50 years old. | ||
**[[Prolactinoma]] occur less commonly in people less than 20 years old, with a prevalence of 10 per 100,000 individuals. These tumors account for less than 2% of intracranial tumors in this age group. | **[[Prolactinoma]] occur less commonly in people less than 20 years old, with a prevalence of 10 per 100,000 individuals. These [[tumors]] account for less than 2% of intracranial [[tumors]] in this age group. | ||
===Gender=== | ===Gender=== | ||
*Women usually have microprolactinoma whereas men usually have macroadenoma. | *Women usually have microprolactinoma whereas men usually have [[Macroadenoma of the pituitary gland|macroadenoma]].<ref name="pmid16411062">{{cite journal| author=Ciccarelli A, Daly AF, Beckers A| title=The epidemiology of prolactinomas. | journal=Pituitary | year= 2005 | volume= 8 | issue= 1 | pages= 3-6 | pmid=16411062 | doi=10.1007/s11102-005-5079-0 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16411062 }} </ref> | ||
*Gender-based frequency of [[prolactinoma]] depends on the age of the individual: | *Gender-based frequency of [[prolactinoma]] depends on the age of the individual: | ||
**Age group: 20 to 50 years | **'''Age group: 20 to 50 years''' | ||
***Women are more commonly affected by [[prolactinoma]] than men. The female to male ratio is approximately 10:1.<ref name="pmid16411062">{{cite journal| author=Ciccarelli A, Daly AF, Beckers A| title=The epidemiology of prolactinomas. | journal=Pituitary | year= 2005 | volume= 8 | issue= 1 | pages= 3-6 | pmid=16411062 | doi=10.1007/s11102-005-5079-0 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16411062 }} </ref> | ***Women are more commonly affected by [[prolactinoma]] than men. The female to male ratio is approximately 10:1.<ref name="pmid16411062">{{cite journal| author=Ciccarelli A, Daly AF, Beckers A| title=The epidemiology of prolactinomas. | journal=Pituitary | year= 2005 | volume= 8 | issue= 1 | pages= 3-6 | pmid=16411062 | doi=10.1007/s11102-005-5079-0 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16411062 }} </ref> | ||
*** | ***Women aged 20 to 30 years have the highest prevalance of [[prolactinoma]], with a female to male ratio of approximately 14:1. | ||
**Age group: >50 years<ref name="pmid7893282">{{cite journal| author=Mindermann T, Wilson CB| title=Age-related and gender-related occurrence of pituitary adenomas. | journal=Clin Endocrinol (Oxf) | year= 1994 | volume= 41 | issue= 3 | pages= 359-64 | pmid=7893282 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7893282 }} </ref> | **'''Age group: >50 years'''<ref name="pmid7893282">{{cite journal| author=Mindermann T, Wilson CB| title=Age-related and gender-related occurrence of pituitary adenomas. | journal=Clin Endocrinol (Oxf) | year= 1994 | volume= 41 | issue= 3 | pages= 359-64 | pmid=7893282 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7893282 }} </ref> | ||
***Men and women are affected equally after age 50. | ***Men and women are affected equally after age 50 years. | ||
***The | ***The [[prevalence]] of [[prolactinoma]] increases with age in men after age 50 and peaks during ages 60 to 70 years. At this time, the female to male ratio is 1:3. | ||
== References == | == References == | ||
| Line 36: | Line 36: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
| |||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Neuroendocrinology]] | [[Category:Neuroendocrinology]] | ||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Endocrinology]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Neurology]] | |||
[[Category:Neurosurgery]] | |||
Latest revision as of 23:49, 29 July 2020
|
Prolactinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Prolactinoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Prolactinoma epidemiology and demographics |
|
Risk calculators and risk factors for Prolactinoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2], Faizan Sheraz, M.D. [3]
Overview
About 45% of pituitary adenomas are prolactinomas, making it the most common type of all pituitary adenomas. Worldwide, the prevalence of sporadic prolactinoma is 6 to 10 per 100,000 persons. The prevalence of prolactinoma in people less than 20 years old is 10 per 100,000 individuals worldwide. Prolactinoma most commonly affects women in reproductive age group (20 to 50 years). Prolactinoma is more common in females than males in people between 20 and 50 years old. Distribution among males and females becomes similar after age 50.
Epidemiology and Demographics
Prevalence
- 45% of pituitary adenomas are prolactinomas, making it the most common type of all pituitary adenomas.[1]
- Worldwide, the prevalence of sporadic prolactinoma ranges from a low of 6 persons per 100,000 persons to a high of 10 persons per 100,000 persons.
- Worldwide, the prevalence of prolactinoma in people less than 20 years old is 10 individuals per 100,000 individuals.
- Clinically significant pituitary tumors affect the health of approximately 14 people per 100,000 people in United States.
- Some growth hormone-producing tumors also co-secrete prolactin.
- Microprolactinoma are much more common than macroprolactinoma.
Incidence
- Worldwide, the incidence of sporadic prolactinoma is 1 person per 100,000 persons per year.[1]
Age
- Age specific distribution of prolactinoma is as follows:[1][2]
- Prolactinoma commonly affects individuals between 20 and 50 years old.
- Prolactinoma occur less commonly in people less than 20 years old, with a prevalence of 10 per 100,000 individuals. These tumors account for less than 2% of intracranial tumors in this age group.
Gender
- Women usually have microprolactinoma whereas men usually have macroadenoma.[1]
- Gender-based frequency of prolactinoma depends on the age of the individual:
- Age group: 20 to 50 years
- Women are more commonly affected by prolactinoma than men. The female to male ratio is approximately 10:1.[1]
- Women aged 20 to 30 years have the highest prevalance of prolactinoma, with a female to male ratio of approximately 14:1.
- Age group: >50 years[2]
- Men and women are affected equally after age 50 years.
- The prevalence of prolactinoma increases with age in men after age 50 and peaks during ages 60 to 70 years. At this time, the female to male ratio is 1:3.
- Age group: 20 to 50 years
References
- ↑ 1.0 1.1 1.2 1.3 1.4 Ciccarelli A, Daly AF, Beckers A (2005). "The epidemiology of prolactinomas". Pituitary. 8 (1): 3–6. doi:10.1007/s11102-005-5079-0. PMID 16411062.
- ↑ 2.0 2.1 Mindermann T, Wilson CB (1994). "Age-related and gender-related occurrence of pituitary adenomas". Clin Endocrinol (Oxf). 41 (3): 359–64. PMID 7893282.